A/63/263
arise, disclosure is important, consistent with the human rights requirements of
transparency.
Associations of pharmaceutical companies
46. So far as these Guidelines bear upon the strategies, policies, programmes,
projects and activities of associations of pharmaceutical companies, they shall
apply equally to all such associations. The Guidelines on lobbying (Guidelines 17
and 26) and financial support (Guideline 18), for example, shall apply equally to all
associations of pharmaceutical companies.
47. A company that is a member of an association of pharmaceutical
companies should take all reasonable steps to ensure that the association fully
conforms to these Guidelines.
Commentary: A company has a responsibility to ensure that its professional
associations are respectful of the right-to-health considerations set out in these
Guidelines; otherwise a company could use an association as a way of avoiding its
human rights responsibilities.
08-45647
25
Select target paragraph3
Connect to a paragraph
Connect to an entity
Disable highlights
Add to table of contents